LifeVantage Corporation (Nasdaq: LFVN) reported financial results for its fourth quarter and full fiscal year ended June 30, 2019.
For the fourth fiscal quarter ended June 30, 2019, the company reported revenue of $56.2 million, an increase of 4.0 percent as compared to $54.0 million in the fourth quarter of fiscal 2018. Revenue in the Americas for the fourth quarter decreased 2.9 percent compared to the fourth quarter of fiscal 2018 and revenue in the Asia/Pacific & Europe region increased 24.4 percent compared to the fourth quarter of fiscal 2018.
Active members increased 3.4 percent to 185,000, including 4.8 percent growth of independent distributors and a 2.6 percent increase in active customers, each on a year over year basis
For the fiscal year ended June 30, 2019, the company reported net revenue of $226.0 million, an increase of 11.2 percent compared to $203.2 million for fiscal 2018. In fiscal 2019, revenue in the Americas increased 7.7 percent and revenue in Asia/Pacific & Europe increased 21.6 percent. Revenue for fiscal 2019 was negatively impacted $1.6 million, or 0.8 percent, by foreign currency fluctuations associated with revenue generated in international markets.
“We are proud to report a strong finish to fiscal 2019, generating the highest annual revenue in the company’s history while exceeding our fiscal 2019 adjusted EPS guidance,” stated LifeVantage President and Chief Executive Officer Darren Jensen. “We continue to see positive trends in our active member counts, reflecting successful execution of each of our 2019 strategic initiatives. We have also expanded our geographic footprint and enhanced our innovative product offering. Looking to fiscal 2020, we remain focused on the key drivers of our continued growth, while embracing new initiatives with the intent to expand these drivers and capitalize on the ever-growing global consumer interest in improving health and enhancing lifestyles.”
To read the full LifeVantage Q4 2019 report, click here.
